Unicycive Therapeutics, Inc.
$3.36
-0.23 (-6.41%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -29.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -40.3%
Own UNCY?
See how UNCY contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.